Soclenicant
Based on 1 Customer Validation
Soclenicant (BNC210) is an orally active α7 nAChR negative alteration modulator (NAM) with no apparent side effects. Soclenicant exhibits acute anxiolytic activity in rodent models of anxiety. Soclenicant inhibits rat and human α7 nAChR currents (in stably transfected cell lines) induced by acetylcholine, nicotine, choline, and the a7-specific agonist PNU-282987 (HY-12560A) with IC50 values in the range of 1.2 to 3 μM. Soclenicant can be used in studies of anxiety, trauma, and stressor-related disorders.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.75%
- CAS No.: 1020634-41-6
- 화학식: C24H26N4O3
- 분자량:418.49
-
보관:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Mean pharmacokinetic parameters following oral administration of Soclenicant (BNC210) to male Sprague Dawley rats at doses of 0.5, 5 and 100 mg/kg[3]
| Parameter | Measured Dose (mg/kg) | Apparent thalf (h) | Cmax (μM) | Tmax (min) | AUC0-tlast (μM*min) | AUC0-inf (μM*min) | AUC0-inf/D (μM*min*kg/μmol) | Apparent BA (%) | % Dose in urine |
| 0.5 mg/kg | 0.55 | c.n.c. | 0.2 | 30 | 53.8 | c.n.c. | 41.4 | 66.7 | 1.6 |
| 5 mg/kg | 4.8 | 8.8 | 1.1 | 30/300/30 | 496.8 | 497.6 | 43.7 | 70.3 | 0.7 |
| 100 mg/kg | 102.4 | 6.3 | 5.7 | 150 | 3055.1 | 3062.9 | 12.5 | 13.2 | 0.2 |